Patients and caregivers interested in participating in the CALMA trial should please contact Santa Cruz Behavioral in Bayamon Puerto Rico. About IGC-AD1 and the CALMA Trial IGC-AD1 is IGC Pharma's ...

POTOMAC, MD / ACCESS Newswire / May 12, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC" or the "Company") today announced that it presented its latest scientific poster, titled "Genetic Toxicity ...

The article was originally published by ABS Canada, and is reprinted here with the author’s permission. The 50th WIPO-IGC session was chaired by Brazilian diplomat Ms. Erika Patriota, who was invested ...

About IGC Pharma (dba IGC): IGC Pharma is an AI-powered, clinical-stage biotechnology company focused on developing innovative treatments for Alzheimer's disease and transforming patient care with ...

In this article, we are going to take a look at where IGC Pharma, Inc. (NYSEAMERICAN:IGC) stands against the other AI stocks. Mark Mahaney, Senior Managing Director at Evercore ISI, discussed how ...

IGC Pharma, Inc. (IGC) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to loss of $0.09 per share a year ago. These figures ...

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational ...

POTOMAC, MD / ACCESS Newswire / January 28, 2025 / IGC Pharma, Inc. (NYSE American:IGC) ("IGC Pharma" or the "Company") is proud to announce its selection as one of the top 15 finalists in the ...

The International Grains Council (IGC) cut its forecast for 2024-25 global corn production, largely reflecting a downward revision for the U.S. crop. IGC forecasts global corn production at 1.219 ...